Displaying items by tag: division of infectious diseases

A monoclonal antibody is being developed by Aridis Pharmaceuticals as an inhaled, self-administered treatment for non-hospitalized patients who are suffering from mild to moderate COVID-19.
The COVID-19 pandemic has impacted many aspects of normal life, but infectious diseases experts explain ways to enjoy the semester while minimizing health risks.
New recommendations for treatment and prevention of HIV infection in adults will help guide physicians and patients in HIV therapies and treatment regimens.
Integration of the telehealth platform in a multiphase optimization strategy evaluation will allow researchers to develop behavioral health approaches that are more realistic and tailored to the individual’s goals and health needs.
While Halloween may look different this year, families can still safely enjoy treat-or-treating with some COVID-friendly changes.
UAB is one of just 100 sites in the nation to receive such an antimicrobial stewardship designation.
A drug that inhibits the protease plasmin is hypothesized to reduce the infectivity and virulence of the virus, as measured by reduced need for hospitalization within a week.
New recommendations for sexual behavior counseling suggest that shorter, more frequent sessions in a clinical setting can be valuable. 
A UAB patient beat COVID-19 and recalls his experience with the virus and enrolling in a clinical trial.
UAB’s Turner Overton, M.D., provides practical ways you can care for your loved ones who have been diagnosed with COVID-19 at home.
To keep your commute safe, practice key hygiene and social distancing, as shared by a UAB Infectious Diseases professor.
A new rapid sexually transmitted infection test developed through research done at UAB will help diagnose and treat patients in real time moving forward.
Page 6 of 12